Immunoediting is a new concept in cancer surveillance. Immunity is involved in detecting cellular waste, and taking off transformed cells. In particular, natural IgM antibodies play an important role in immunosurveillance mechanisms against transformed cells in humans.? Scientific evidence indicates that biomarkers for different types of cancer, such as liver and colorectal cancer, circulate in blood associated with immunoglobulin M (IgM) to form complexes that improve diagnosis in comparison to circulating free biomarkers. In prostate cancer it has been demonstrated that testing for serum levels of the PSA-IgM immune complex improves the diagnostic performance of total PSA. Preliminary reports indicate that the combination of PSA-IgM with ...
Background Prostate cancer (PCa) is the most common malignancy among men in the United States. Thoug...
Objective Antiprostasome antibodies (APAs) have been identified in serum of patients with prostate c...
BACKGROUND: In the sera of liver, colorectal and prostate cancer patients, several biomarkers may b...
BACKGROUND In spite of recent advances in treatment strategies, prostate cancer (PCa) remains the se...
Surprisingly perhaps for a tumor where there is such clear proof of a primary hormonal basis to its ...
Abstract Background Prostate cancer (PCa) is the second leading cause of cancer deaths in men in the...
In forty-four patients with different prostatic lesions serum immunoglobulins and tissue deposited i...
We previously demonstrated that IgG responses to a panel of 126 prostate tissue-associated antigens ...
Several mechanisms that impair the immune response to promote tumour progression are reported. These...
Prostate cancer is the most common non-cutaneous malignancy in men and is the second leading cause o...
This study was aimed at defining molecular species of prostate-specific antigen (PSA) in immune comp...
The differential diagnosis of prostate cancer is problematic due to the lack of markers with high di...
Prostate cancer (PCa) is the most common cancer in men and the second most common cause of cancer-re...
Active immunotherapy is dependent on the ability of the immune system to recognize and respond to tu...
Immunotherapy is being tested intensively in clinical trials for prostate cancer; it includes immune...
Background Prostate cancer (PCa) is the most common malignancy among men in the United States. Thoug...
Objective Antiprostasome antibodies (APAs) have been identified in serum of patients with prostate c...
BACKGROUND: In the sera of liver, colorectal and prostate cancer patients, several biomarkers may b...
BACKGROUND In spite of recent advances in treatment strategies, prostate cancer (PCa) remains the se...
Surprisingly perhaps for a tumor where there is such clear proof of a primary hormonal basis to its ...
Abstract Background Prostate cancer (PCa) is the second leading cause of cancer deaths in men in the...
In forty-four patients with different prostatic lesions serum immunoglobulins and tissue deposited i...
We previously demonstrated that IgG responses to a panel of 126 prostate tissue-associated antigens ...
Several mechanisms that impair the immune response to promote tumour progression are reported. These...
Prostate cancer is the most common non-cutaneous malignancy in men and is the second leading cause o...
This study was aimed at defining molecular species of prostate-specific antigen (PSA) in immune comp...
The differential diagnosis of prostate cancer is problematic due to the lack of markers with high di...
Prostate cancer (PCa) is the most common cancer in men and the second most common cause of cancer-re...
Active immunotherapy is dependent on the ability of the immune system to recognize and respond to tu...
Immunotherapy is being tested intensively in clinical trials for prostate cancer; it includes immune...
Background Prostate cancer (PCa) is the most common malignancy among men in the United States. Thoug...
Objective Antiprostasome antibodies (APAs) have been identified in serum of patients with prostate c...
BACKGROUND: In the sera of liver, colorectal and prostate cancer patients, several biomarkers may b...